Autophagy in acute myeloid leukemia: a paradoxical role in chemoresistance

Khan, Aafreen; Kumar Singh, Vivek; Thakral, Deepshi; Gupta, Ritu.
Clin. transl. oncol. (Print) ; 24(8): 1459-1469, agosto 2022. ilus
Artículo en Inglés | IBECS (España) | ID: ibc-206235

Documentos relacionados

  1. Acute Myeloid Leukemia in Patients Living with HIV Infection: Several Questions, Fewer Answers.
  2. Predictive value of molecular remissions postconsolidation chemotherapy in patients with Core Binding Factor Acute Myeloid Leukemia (CBF-AML) - a single center analysis.
  3. Outcomes and survival predictors of Latin American older adults with acute myeloid leukemia: Data from a single center
  4. The devil is in the details: confidentiality challenges in the age of genetics.
  5. Fasting to enhance Cancer treatment in models: the next steps.
  6. Validation of a computerized decision support system to review pharmacotherapy treatment: scheduling guidelines.
  7. Healthcare Costs and Utilization for Patients Age 50 to 64 Years with Acute Myeloid Leukemia Treated with Chemotherapy or with Chemotherapy and Allogeneic Hematopoietic Cell Transplantation.
  8. Do quality of life or physical function at diagnosis predict short-term outcomes during intensive chemotherapy in AML?
  9. The biochemistry of disease: desperately seeking syzygy.
  10. Validation of the Functional Assessment of Cancer Therapy-Leukemia instrument in patients with acute myeloid leukemia who are not candidates for intensive therapy.